Skip to main content
Top
Published in: Diabetologia 12/2009

01-12-2009 | Article

Genetic influences on the insulin response of the beta cell to different secretagogues

Authors: A. M. C. Simonis-Bik, E. M. W. Eekhoff, M. H. M. de Moor, M. H. H. Kramer, D. I. Boomsma, R. J. Heine, J. M. Dekker, J. A. Maassen, L. M. ’t Hart, M. Diamant, E. J. C. de Geus

Published in: Diabetologia | Issue 12/2009

Login to get access

Abstract

Aims/hypothesis

The aim of the present study was to estimate the heritability of the beta cell insulin response to glucose and to glucose combined with glucagon-like peptide-1 (GLP-1) or with GLP-1 plus arginine.

Methods

This was a twin-family study that included 54 families from the Netherlands Twin Register. The participants were healthy twin pairs and their siblings of the same sex, aged 20 to 50 years. Insulin response of the beta cell was assessed by a modified hyperglycaemic clamp with additional GLP-1 and arginine. Insulin sensitivity index (ISI) was assessed by the euglycaemic–hyperinsulinaemic clamp. Multivariate structural equation modelling was used to obtain heritabilities and the genetic factors underlying individual differences in BMI, ISI and secretory responses of the beta cell.

Results

The heritability of insulin levels in response to glucose was 52% and 77% for the first and second phase, respectively, 53% in response to glucose + GLP-1 and 80% in response to an additional arginine bolus. Insulin responses to the administration of glucose, glucose + GLP-1 and glucose + GLP-1 + arginine were highly correlated (0.62< r <0.79). Heritability of BMI and ISI was 74% and 60% respectively. The genetic factors that influenced BMI and ISI explained about half of the heritability of insulin levels in response to the three secretagogues. The other half was due to genetic factors specific to the beta cell.

Conclusions/interpretation

In healthy adults, genetic factors explain most of the individual differences in the secretory capacity of the beta cell. These genetic influences are partly independent from the genes that influence BMI and ISI.
Appendix
Available only for authorised users
Literature
1.
go back to reference No authors listed (2003) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26(Suppl 1):S5–S20 No authors listed (2003) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26(Suppl 1):S5–S20
2.
go back to reference Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763–768CrossRefPubMed Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30:763–768CrossRefPubMed
3.
go back to reference Kaprio J, Tuomilehto J, Koskenvuo M et al (1992) Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060–1067CrossRefPubMed Kaprio J, Tuomilehto J, Koskenvuo M et al (1992) Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060–1067CrossRefPubMed
4.
go back to reference Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD (1999) Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 42:146–150CrossRefPubMed Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD (1999) Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 42:146–150CrossRefPubMed
5.
go back to reference Beck-Nielsen H, Vaag A, Poulsen P, Gaster M (2003) Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects—experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 17:445–467CrossRefPubMed Beck-Nielsen H, Vaag A, Poulsen P, Gaster M (2003) Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects—experiences from relatives and twin studies. Best Pract Res Clin Endocrinol Metab 17:445–467CrossRefPubMed
6.
go back to reference Watanabe RM, Valle T, Hauser ER et al (1999) Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered 49:159–168CrossRefPubMed Watanabe RM, Valle T, Hauser ER et al (1999) Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered 49:159–168CrossRefPubMed
7.
go back to reference Hsueh WC, Mitchell BD, Aburomia R et al (2000) Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care 23:595–601CrossRefPubMed Hsueh WC, Mitchell BD, Aburomia R et al (2000) Diabetes in the Old Order Amish: characterization and heritability analysis of the Amish Family Diabetes Study. Diabetes Care 23:595–601CrossRefPubMed
8.
go back to reference Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49:2201–2207CrossRefPubMed Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49:2201–2207CrossRefPubMed
9.
go back to reference Hanson RL, Imperatore G, Narayan KM et al (2001) Family and genetic studies of indices of insulin sensitivity and insulin secretion in Pima Indians. Diabetes Metab Res Rev 17:296–303CrossRefPubMed Hanson RL, Imperatore G, Narayan KM et al (2001) Family and genetic studies of indices of insulin sensitivity and insulin secretion in Pima Indians. Diabetes Metab Res Rev 17:296–303CrossRefPubMed
10.
go back to reference Mills GW, Avery PJ, McCarthy MI et al (2004) Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia 47:732–738CrossRefPubMed Mills GW, Avery PJ, McCarthy MI et al (2004) Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia 47:732–738CrossRefPubMed
11.
go back to reference Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L (2000) Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia 43:285–293CrossRefPubMed Lehtovirta M, Kaprio J, Forsblom C, Eriksson J, Tuomilehto J, Groop L (2000) Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia 43:285–293CrossRefPubMed
12.
go back to reference Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54:275–283CrossRefPubMed Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54:275–283CrossRefPubMed
13.
go back to reference Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662CrossRefPubMed Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662CrossRefPubMed
14.
go back to reference Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100–1110CrossRefPubMed Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100–1110CrossRefPubMed
15.
go back to reference Elbein SC, Hasstedt SJ, Wegner K, Kahn SE (1999) Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 84:1398–1403CrossRefPubMed Elbein SC, Hasstedt SJ, Wegner K, Kahn SE (1999) Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 84:1398–1403CrossRefPubMed
16.
go back to reference Hong Y, Weisnagel SJ, Rice T et al (2001) Familial resemblance for glucose and insulin metabolism indices derived from an intravenous glucose tolerance test in Blacks and Whites of the HERITAGE Family Study. Clin Genet 60:22–30CrossRefPubMed Hong Y, Weisnagel SJ, Rice T et al (2001) Familial resemblance for glucose and insulin metabolism indices derived from an intravenous glucose tolerance test in Blacks and Whites of the HERITAGE Family Study. Clin Genet 60:22–30CrossRefPubMed
17.
go back to reference Lehtovirta M, Kaprio J, Groop L, Trombetta M, Bonadonna RC (2005) Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. Diabetologia 48:1604–1613CrossRefPubMed Lehtovirta M, Kaprio J, Groop L, Trombetta M, Bonadonna RC (2005) Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. Diabetologia 48:1604–1613CrossRefPubMed
18.
go back to reference Gautier JF, Fetita S, Sobngwi E, Salaun-Martin C (2005) Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab 31:233–242CrossRefPubMed Gautier JF, Fetita S, Sobngwi E, Salaun-Martin C (2005) Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes Metab 31:233–242CrossRefPubMed
19.
go back to reference Brandle M, Lehmann R, Maly FE, Schmid C, Spinas GA (2001) Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes Care 24:1253–1258CrossRefPubMed Brandle M, Lehmann R, Maly FE, Schmid C, Spinas GA (2001) Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes Care 24:1253–1258CrossRefPubMed
20.
go back to reference Stumvoll M, Fritsche A, Haring HU (2002) Clinical characterization of insulin secretion as the basis for genetic analyses. Diabetes 51(Suppl 1):S122–S129CrossRefPubMed Stumvoll M, Fritsche A, Haring HU (2002) Clinical characterization of insulin secretion as the basis for genetic analyses. Diabetes 51(Suppl 1):S122–S129CrossRefPubMed
21.
go back to reference Fritsche A, Stefan N, Hardt E, Schutzenauer S, Haring H, Stumvoll M (2000) A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility. Eur J Clin Invest 30:411–418CrossRefPubMed Fritsche A, Stefan N, Hardt E, Schutzenauer S, Haring H, Stumvoll M (2000) A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility. Eur J Clin Invest 30:411–418CrossRefPubMed
22.
go back to reference Gerich JE (2002) Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 51(Suppl 1):S117–S121CrossRefPubMed Gerich JE (2002) Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes? Diabetes 51(Suppl 1):S117–S121CrossRefPubMed
23.
go back to reference Ahren B, Pacini G (2004) Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 150:97–104CrossRefPubMed Ahren B, Pacini G (2004) Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 150:97–104CrossRefPubMed
24.
go back to reference Boomsma DI, de Geus EJC, Vink JM et al (2006) Netherlands Twin Register: from twins to twin families. Twin Res Hum Genet 9:849–857CrossRefPubMed Boomsma DI, de Geus EJC, Vink JM et al (2006) Netherlands Twin Register: from twins to twin families. Twin Res Hum Genet 9:849–857CrossRefPubMed
25.
go back to reference Simonis-Bik AM, Eekhoff EM, Diamant M et al (2008) The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Res Hum Genet 11:597–602CrossRefPubMed Simonis-Bik AM, Eekhoff EM, Diamant M et al (2008) The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Res Hum Genet 11:597–602CrossRefPubMed
26.
go back to reference Posthuma D, Boomsma DI (2000) A note on the statistical power in extended twin designs. Behav Genet 30:147–158CrossRefPubMed Posthuma D, Boomsma DI (2000) A note on the statistical power in extended twin designs. Behav Genet 30:147–158CrossRefPubMed
27.
go back to reference DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
28.
go back to reference Snijder MB, Dekker JM, Visser M et al (2003) Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 77:1192–1197PubMed Snijder MB, Dekker JM, Visser M et al (2003) Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr 77:1192–1197PubMed
29.
go back to reference Astles JR, Sedor FA, Toffaletti JG (1996) Evaluation of the YSI 2300 glucose analyzer: algorithm-corrected results are accurate and specific. Clin Biochem 29:27–31CrossRefPubMed Astles JR, Sedor FA, Toffaletti JG (1996) Evaluation of the YSI 2300 glucose analyzer: algorithm-corrected results are accurate and specific. Clin Biochem 29:27–31CrossRefPubMed
30.
go back to reference Neale MC, Boker SM, Xie G, Maes HH (2006) Mx: Statistical modeling, 7th edn. Virginia Commonwealth University Department of Psychiatry, Richmond Neale MC, Boker SM, Xie G, Maes HH (2006) Mx: Statistical modeling, 7th edn. Virginia Commonwealth University Department of Psychiatry, Richmond
31.
go back to reference Neale MC, Cardon LR (1992) Methodology for genetic studies of twins and families. Kluwer, Dordrecht Neale MC, Cardon LR (1992) Methodology for genetic studies of twins and families. Kluwer, Dordrecht
32.
go back to reference Huxley R, James WPT, Barzi F et al (2008) Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 9(Suppl 1):53–61CrossRefPubMed Huxley R, James WPT, Barzi F et al (2008) Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 9(Suppl 1):53–61CrossRefPubMed
33.
go back to reference Maes HH, Neale MC, Eaves LJ (1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27:325–351CrossRefPubMed Maes HH, Neale MC, Eaves LJ (1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27:325–351CrossRefPubMed
34.
go back to reference Frayling TM, Timpson NJ, Weedon MN et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–894CrossRefPubMed Frayling TM, Timpson NJ, Weedon MN et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–894CrossRefPubMed
35.
go back to reference Prokopenko I, McCarthy MI, Lindgren CM (2008) Type 2 diabetes: new genes, new understanding. Trends Genet 24:613–621CrossRefPubMed Prokopenko I, McCarthy MI, Lindgren CM (2008) Type 2 diabetes: new genes, new understanding. Trends Genet 24:613–621CrossRefPubMed
36.
go back to reference Groenewoud MJ, Dekker JM, Fritsche A et al (2008) Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 51:1659–1663CrossRefPubMed Groenewoud MJ, Dekker JM, Fritsche A et al (2008) Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia 51:1659–1663CrossRefPubMed
37.
go back to reference Schafer SA, Tschritter O, Machicao F et al (2007) Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50:2443–2450CrossRefPubMed Schafer SA, Tschritter O, Machicao F et al (2007) Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50:2443–2450CrossRefPubMed
38.
go back to reference Schafer SA, Mussig K, Staiger H et al (2009) A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion. Diabetologia 52:1075–1082CrossRefPubMed Schafer SA, Mussig K, Staiger H et al (2009) A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion. Diabetologia 52:1075–1082CrossRefPubMed
39.
go back to reference Haupt A, Guthoff M, Schafer SA et al (2009) The inhibitory association of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity. J Clin Endocrinol Metab 94:1775–1780CrossRefPubMed Haupt A, Guthoff M, Schafer SA et al (2009) The inhibitory association of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity. J Clin Endocrinol Metab 94:1775–1780CrossRefPubMed
40.
go back to reference McCarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9:164–171CrossRefPubMed McCarthy MI, Zeggini E (2009) Genome-wide association studies in type 2 diabetes. Curr Diab Rep 9:164–171CrossRefPubMed
Metadata
Title
Genetic influences on the insulin response of the beta cell to different secretagogues
Authors
A. M. C. Simonis-Bik
E. M. W. Eekhoff
M. H. M. de Moor
M. H. H. Kramer
D. I. Boomsma
R. J. Heine
J. M. Dekker
J. A. Maassen
L. M. ’t Hart
M. Diamant
E. J. C. de Geus
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 12/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1532-3

Other articles of this Issue 12/2009

Diabetologia 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.